News
Sumitomo Dainippon Pharma and Exscientia announce that a phase I clinical study of DSP-1181, that was created using Artificial Intelligence (AI), has been initiated in Japan for the treatment of obsessive-compulsive disorder as an initial indication.
News
A protocol for utilizing human peripheral blood neutrophils for research into the Parkinson’s disease associated LRRK2 kinase has been published.
Press release
A drug developed at the University of Dundee for a neglected tropical disease could be repurposed to treat leukaemia following Fast Track Designation by the U.S. Food and Drug Administration (FDA).
News
Dr Arpan Mehta, a neurologist specialising in Amyotrophic Lateral Sclerosis (ALS), has joined the Medical Research Council Protein Phosphorylation and Ubiquitylation Unit (MRC-PPU) in the School of Life Sciences.
Press release
University of Dundee researchers have discovered a new neurodevelopmental disease caused by genetic mutations and helped explain why patients with these mutations suffer this condition.
News
Researchers in the School have discovered a new neurodevelopmental disease caused by genetic mutations and helped explain why patients with these mutations suffer this condition.
News
Eight years ago it was discovered that the SIK subfamily of protein kinases suppress the production of the anti-inflammatory cytokine IL-10 by phosphorylating and activating CRTC3, co-activator of the transcription factor CREB.
Press release
Five University of Dundee academics are among the newest Fellows elected to the Royal Society of Edinburgh (RSE).
News
Dr Raja Nirujogi, who has been working in the MRC Protein Phosphorylation and Ubiquitylation Unit since 2017 has been appointed as an Independent Investigator within the School of Life Sciences.
Feature
While scientists at the University of Dundee conduct ground-breaking research into Parkinson’s disease, transferring that knowledge into the real world is equally important
Press release
Amphista Therapeutics, a University of Dundee spinout company, has announced a near-£40 million investment that will further its work to develop new drugs for a range of diseases.
Press release
The acidity of tumours impairs the effectiveness of anti-cancer therapies, according to a University of Dundee study that could lead to a new generation of immunotherapy treatments
News
The Drug Discovery Unit (DDU) in the School has generated £2.7 million income to the University from industrial collaborations for their high quality therapeutic projects where there is a clinical unmet need.
News
Amphista Therapeutics, the spin out company from the lab of Professor Alessio Ciulli, was awarded the ‘Financing Deal of the Year’ award 2021 at the Scrip Awards last month. This was in recognition of their $53M Series B funding.
Impact case study
Bringing about step-change in the diagnosis and treatment of neglected tropical diseases.
News
DEBRA is delighted to share that funding for a fourth year of the University of Dundee’s research into novel gene technology for treating Epidermolysis Bullosa (EB) has been agreed.
Press release
The University of Dundee has been confirmed as one of the UK’s leading research centres for biological sciences, according to the results of the Research Excellence Framework (REF 2021)
News
Dr Susan Wyllie has been awarded the prestigious C.A. Wright Memorial Medal from the British Society for Parasitology in recognition of her outstanding contribution to the discipline.
Press release
Researchers at the University of Dundee are looking to transform pharmaceutical and cosmetics testing with their spinout venture that offers an alternative for many experiments currently only performed in animals.
Press release
Mouse models with a human drug metabolism have the potential to transform preclinical research, say University of Dundee experts.